MYC基因在人肿瘤中致癌作用的泛癌分析-现代医学

MYC基因在人肿瘤中致癌作用的泛癌分析

作者：王恒赵春

单位：江苏省中医院检验科, 江苏南京 210029

分类号：R34

出版年·卷·期（页码）：2021·49·第八期（877-883）

摘要：

目的：研究MYC基因在人肿瘤组织内的基因及蛋白表达，并探讨其临床意义。方法：对TCGA和GEO数据库进行深入挖掘，观察MYC基因在肿瘤组织中的表达情况，并分析其与肿瘤预后的关系、发生突变情况、磷酸化水平以及免疫浸润和相关通路的情况。结果：MYC基因在多种肿瘤组织中的表达升高，表达的高低关系到不同类型肿瘤患者的预后，在卵巢癌、子宫肉瘤和食管癌患者中MYC的突变率最高，在乳腺浸润癌、卵巢癌和结肠癌中MYC的磷酸化水平更高，在不同肿瘤中MYC的表达与免疫浸润呈相关性，MYC可能通过“RNA转录”和“细胞周期”的通路参与了肿瘤的发生。结论：MYC在不同的肿瘤中都有表达，MYC的功能机制与蛋白质加工和RNA代谢密切相关。

Objective: To explore the oncogenic roles of MYC in tumors based on the database of TCGA(The cancer genome atlas) and GEO(Gene expression omnibus).Methods: We tried to research the associations between MYC expression and prognosis,genetic alteration, phosphorylation level, immune infiltration and gene enrichment pathway of tumor.Results: MYC was highly expressed in most ofcancers,the level of MYC expression is related to the prognosis of patients with different types of tumors.We observed the genetic alteration status of MYC in different tumor samples, the highest alteration frequency of MYC appeard in patients with ovarian serous cystadenocarcinoma, uterine carcinosarcoma and esophageal adenocarcinoma tumors. We compared the differences of MYC phosphorylation levels between normal tissues and primary tumor tissues. MYC exhibitedhigher phosphorylation level in breast invasive carcinoma,ovarian serous cystadenocarcinoma and colon adenocarcinoma tumor tissues compared with the normal tissues.we observed a statistical positive correlation of MYC expression and the infiltration value of cancer-associated fibroblasts for the tumors."RNA transcription" and "cell cycle" might be involved in the effect of MYC on tumor pathogenesis. Conclusions: MYC is expressed in differentcancers, whose functional mechanisms may be associated with protein processing and RNA metabolism.

参考文献：

[1] 周逸琳, 郑弘毅, 刘瑶.MYC的研究进展[J]. 赣南医学院学报, 2017.37(1):140-145.
[2] 柯晴, 段莹, 黄文强, 等.MYC在弥漫大B细胞淋巴瘤的表达及其临床意义[J]. 中国癌症防治杂志, 2019, 11(4):289-296.
[3] LI T, FU J, ZENG Z, et al. TIMER 2.0 for analysis of tumor-infiltrating immune cells[J]. Nucleic Acids Res, 2020, 48(W1):W509-W514.
[4] TANG Z, KANG B, LI C, et al. GEPIA2:an enhanced web server for large-scale expression profiling and interactive analysis[J]. Nucleic Acids Res, 2019, 47(W1):W556-W560.
[5] SHAO W, HAN Z, CHENG J, et al. Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis[J]. IEEE Trans Med Imaging, 2020, 39(1):99-110.
[6] CHANDRASHEKAR D S, BASHEL B, BALASUBRAMANYA S, et al. UALCAN:a portal for facilitating tumor subgroup gene expression and survival analyses[J]. Neoplasia, 2017, 19(8):649-658.
[7] FRIDMAN W H, GALON J, DIEU-NOSJEAN M C, et al. Immune infiltration in human cancer:prognostic significance and disease control[J]. Curr Top Microbiol Immunol, 2011, 344(4):1-24.
[8] STEVEN A, SELIGER B.The role of immune escape and immune cell infiltration in breast cancer[J]. Breast Care(Basel), 2018, 13(1):16-21.
[9] CHEN X, SONG E.Turning foes to friends:targeting cancer-associated fibroblasts[J]. Nat Rev Drug Discov, 2019, 18(2):99-115.
[10] KWA M Q, HERUM K M, BRAKEBUSCH C.Cancer-associated fibroblasts:how do they contribute to metastasis[J]. Clin Exp Metastasis, 2019, 36(2):71-86.
[11] 俞今晶, 来纯云.c-Myc在肿瘤中的表达及功能[J]. 国际肿瘤学杂志, 2017, 44(4):278-280.
[12] 魏洁, 范林妮, 李侠, 等.中国人Burkitt淋巴瘤中ID3、TCF3及MYC基因突变分析[J]. 临床与实验病理学杂志, 2016, 32(12):1343-1347.
[13] 张丽敏, 洪专.多西紫杉醇和顺铂联合用药对人乳腺癌MCF-7细胞hTERT及C-myc基因表达的影响[J]. 现代医学, 2008, 36(6):422-425.
[14] BALUAPURI A, WOLF E, EILERS M.Target gene-independent functions of MYC oncoproteins[J]. Nat Rev Mol Cell Biol, 2020, 21(5):255-267.

服务与反馈：

【文章下载】【发表评论】【查看评论】【加入收藏】

提示：您还未登录，请登录！点此登录